Do you want to link to this External Website and leave Amgen.nl?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Netherlands takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Care solutions

Trends & developments

The demand for healthcare in the Netherlands has increased significantly in recent decades, amongst others due to aging, higher life expectancy and an increase in chronic diseases. To guarantee access to high quality healthcare, now and in the future, Amgen has taken the initiative to develop innovative healthcare solutions, which will unburden the healthcare system, by replacing and transferring hospital care to home. These care solutions have one priority: offering the right care to the right patient at the right location.

Caresolutions team

Amgen’s caresolutions team is, together with patients, care providers and other parties within and outside the healthcare sector, engaged in the (further) development of our healthcare solutions. We are in daily contact with all those stakeholders in order to contribute to a successful treatment for every patient.

Valuable support

Our care solutions are quadruple, all of which are supported by analyzing Real World Data (RWD) and monitoring the outcomes of a patient's treatment.

  • First, there are our smart devices, such as an 'on-body injector' for oncology patients, with which we can provide patients with the necessary treatment on time at home;
  • Then there is our ambition to support hospitals in moving their care services to home;
  • We are also continuously innovating our online support - such as the development of an accessible patient portal;
  • Finally - and most comprehensively - there is the AmgenCare program, which offers support to the individual patient at home to help increase therapy compliance.

Together, these four healthcare solutions form a tailor-made solution with which we, together with our partners, support the healthcare system on a daily basis

Our AmgenCare program







Via AmgenCare, we can offer specialist care at home, tailored to the specific needs of patients within specific indications, in collaboration with our home care vendors. This includes extensive explanation and help with medication administering at home, offering doctors insight into the treatment of their patients, online support for the patient, monitoring adherence and the result of the treatment, and measuring patient satisfaction in our AmgenCare programs.

AmgenCare encompasses a number of specific care programs developed for patients specifically related to their disease profile. By now, these AmgenCare programs have existed for over 20 years, and during that time over 50.000 patients have been supported with these programs. These care programs include amongst other things home delivery of medication, administration and specialist care, extensive information and instruction on the use of the medication so that the patient can take over (depending on the type of medication), taking blood values, offering online support via a patient platform, and monitoring therapy compliance and treatment outcome.

See below for a short description per program.







The AmgenCare cardiovascular program offers digital and physical services, through which the program contributes to achieving optimal therapy compliance and cholesterol (LDL-c) target values in (high-risk) cardiovascular patients. These services include at-home delivery, medicinal administration and instruction on the medication by a nurse, periodic feedback on LDL-c values to physician and patient, 24/7 customer service and a digital patient portal.

The AmgenCare oncology program includes at-home delivery and medicinal administration, instruction on the medication by a nurse, additional information provision depending on the treatment to be followed, and 24/7 customer service. The program is aimed at reducing the burden of treatment and the disease process as much as possible through personal guidance and its services.

The AmgenCare hematology program focuses on at-home infusion therapies for patients with Multiple Myeloma. The at home administration of the treatment reduces travel and waiting time, subsequently decreasing the burden of disease for patients and/or caregivers. As such, the program contributes to the quality of life and the maintenance of therapy compliance.

The AmgenCare bone program aims to empower people with an increased fracture risk to self-inject their medical treatment. To this end, an injection instruction is given at home by a specialized nurse, supportive material is made available for the patient, and medication is delivered at home.

AmgenCare nephrology is specifically designed for patients suffering from anemia due to chronic kidney failure. With at-home delivery and administration of the medication and targeted information about their condition and treatment, the program helps patients to continue their own treatment with the least possible impact.





Through the AmgenCare donor program, Amgen specifically contributes to an increase in the number of (unrelated) stem cell donations. The program facilitates for as many unrelated donors as possible to help patients with stem cell transplantations. The program includes injection, instruction and guidance of donors at home (or on location), every day of the week. This reduces the burden on the donor and provides more flexibility in the planning of donations and stem cell procurement, which results in an increase in stem cell transplants.

Reference:
1. Kantar Public Customer & Patient Survey 2018

Questions?

Would you like to know more about the various (home) care programs? Please contact Amgen BV.

In this section

Our medicinesicon

Amgen discovers, develops, produces and supplies innovative medicines for patients suffering from serious diseases.

Outcome based solutionsicon

We look beyond our medicines. With our outcome based solutions, such as our care and value solutions, we try to add value for the patient.

Amgen biosimilarsicon

Biosimilars are biologic medicines that are highly similar to existing licensed biologic products. They offer the possibility to give a larger group of patients access to essential medicines.

Medical informationicon

Medical questions about our medicines? You can contact us here.